Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Leukemia

Free Subscription 29.09.2025 1 Am J Clin Pathol 2 Ann Hematol 3 Blood 1 Bone Marrow Transplant 1 Cancer Lett 2 Genes Chromosomes Cancer 1 Leuk Res 3 Leukemia 2 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Pathol

1. SEGURA RNL, Nardi V, Hoang MP
   Role of nucleophosmin 1 immunostain in detecting leukemia cutis of acute myeloid leukemia with NPM1 mutation.
   Am J Clin Pathol. 2025 Sep 17:aqaf089. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Ann Hematol

2. LI J, Yuan Y, Niu FF, Wang Y, et al
   USP7 mutations are associated with adverse outcomes in pediatric T cell acute lymphoblastic leukemia and lymphoma.
   Ann Hematol. 2025 Sep 22. doi: 10.1007/s00277-025-06582.
   PubMed         Abstract available
   
   
3. RANTI J, Jamalzadeh S, Makela E, Vikkula J, et al
   Real-world study on patient characteristics, treatment patterns and outcomes for treated patients with chronic lymphocytic leukemia during 2013-2022 in Finland.
   Ann Hematol. 2025 Sep 19. doi: 10.1007/s00277-025-06595.
   PubMed         Abstract available
   
   

   
   Blood

4. MATEOS-JAIMEZ J, Vidal Crespo A, Charalampopoulou S, Fernandez Perez R, et al
   INCREASED LEF1 PROTEIN LEVELS AND ISOFORM SWITCHING DRIVE CELL PROLIFERATION IN CHRONIC LYMPHOCYTIC LEUKEMIA.
   Blood. 2025 Sep 22:blood.2025030129. doi: 10.1182/blood.2025030129.
   PubMed         Abstract available
   
   
5. NEVEN Q, Arfeuille C, Caye-Eude A, Durand P, et al
   The watch-and-wait approach for patients with juvenile myelomonocytic leukemia: results of the French cohort.
   Blood. 2025 Sep 19:blood.2025029916. doi: 10.1182/blood.2025029916.
   PubMed         Abstract available
   
   
6. ANDRICOVICH J, Lap CJ, Tzatsos A
   Loss of BAP1 defines a unique subtype of TP53-mutated de novo AML and confers sensitivity to BCL-xL inhibitors.
   Blood. 2025;146:1493-1510.
   PubMed         Abstract available
   
   

   
   Bone Marrow Transplant

7. MORSINK LM, Keijzer K, Hazenberg CLE, Choi G, et al
   Beneficial effect of PTCy and a short duration of immune suppression on relapse risk in acute myeloid leukemia patients with pretransplant MRD.
   Bone Marrow Transplant. 2025 Sep 19. doi: 10.1038/s41409-025-02716.
   PubMed        
   
   

   
   Cancer Lett

8. CAI M, Xia Z, Shao C, Du W, et al
   P2RY8::TSC22D3 is a novel fusion associated with chemoresistance in leukemia by activating PI3K-AKT pathway.
   Cancer Lett. 2025;633:218040.
   PubMed        
   
   

   
   Genes Chromosomes Cancer

9. ZHANG H, Liu X, Wang X, Zhang Q, et al
   Cytogenetic and Molecular Genetic Driven Prediction of Response to First-Treatment and Prognosis in Acute Myeloid Leukemia: A Retrospective Cohort Study.
   Genes Chromosomes Cancer. 2025;64:e70081.
   PubMed         Abstract available
   
   
10. URBANSKI B, Miarka-Walczyk K, Urbanska Z, Wasikowska M, et al
    IGH::IL3-Rearranged B-Cell Precursor Acute Lymphoblastic Leukemia With Hypereosinophilia in a Child With a Novel PAX5 Germline Variant.
    Genes Chromosomes Cancer. 2025;64:e70080.
    PubMed         Abstract available
    
    

    
    Leuk Res

11. CLAIBORNE JP, Li D, Tsai HL, Ghiaur G, et al
    Efficacy and safety of blinatumomab for CD19?+?acute leukemias in patients historically excluded from clinical trials due to comorbidities.
    Leuk Res. 2025;157:108098.
    PubMed         Abstract available
    
    

    
    Leukemia

12. VISENTIN A, Gaffo E, Furstenau M, Rogers KA, et al
    Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study.
    Leukemia. 2025 Sep 19. doi: 10.1038/s41375-025-02755.
    PubMed         Abstract available
    
    
13. MAZZEO P, Penir SM, Shumilov E, Wolf S, et al
    Clonal evolution and apoptosis resistance in myelodysplastic neoplasms and acute myeloid leukemia under treatment: insights from integrative longitudinal profiling.
    Leukemia. 2025 Sep 19. doi: 10.1038/s41375-025-02756.
    PubMed         Abstract available
    
    
14. CUSAN M, Larkin K, Nicolet D, Jurinovic V, et al
    Multi-dimensional analysis of adult acute myeloid leukemia cross-continents reveals age-associated trends in mutational landscape and treatment outcomes (Acute Myeloid Leukemia Cooperative Group & Alliance for Clinical Trials in Oncology).
    Leukemia. 2025 Sep 19. doi: 10.1038/s41375-025-02644.
    PubMed         Abstract available
    
    

    
    PLoS One

15. SINGH AP, Wax N, Duncan J, Fernandes AS, et al
    Genomic discovery of EF-24 targets unveils antitumorigenic mechanisms in leukemia cells.
    PLoS One. 2025;20:e0330906.
    PubMed         Abstract available
    
    
16. MUNROE M, Chamba C, Yonazi M, Mahfudh S, et al
    Low survival in younger adults with Acute Myeloid Leukemia (AML) in Tanzania linked to high disease burden and socioeconomic factors.
    PLoS One. 2025;20:e0332237.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

17. HAZIME KS, Sheppard S, Niembro-Vivanco O, Hosty C, et al
    Nanoscale restructuring of the immune synapse with an engager enhances NK cell function.
    Proc Natl Acad Sci U S A. 2025;122:e2507336122.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.